Cargando…

Autologous organoid co-culture model reveals T cell-driven epithelial cell death in Crohn’s Disease

Lympho-epithelial interactions between intestinal T resident memory cells (Trm) and the epithelium have been associated with inflammatory bowel disease (IBD) activity. We developed ex vivo autologous organoid-mucosal T cell cocultures to functionally assess lymphoepithelial interactions in Crohn’s D...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammoudi, Nassim, Hamoudi, Sarah, Bonnereau, Julie, Bottois, Hugo, Pérez, Kevin, Bezault, Madeleine, Hassid, Déborah, Chardiny, Victor, Grand, Céline, Gergaud, Brice, Bonnet, Joëlle, Chedouba, Leila, Tran Minh, My-Linh, Gornet, Jean-Marc, Baudry, Clotilde, Corte, Hélène, Maggiori, Léon, Toubert, Antoine, McBride, Jacqueline, Brochier, Camille, Neighbors, Margaret, Le Bourhis, Lionel, Allez, Matthieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685428/
https://www.ncbi.nlm.nih.gov/pubmed/36439157
http://dx.doi.org/10.3389/fimmu.2022.1008456
Descripción
Sumario:Lympho-epithelial interactions between intestinal T resident memory cells (Trm) and the epithelium have been associated with inflammatory bowel disease (IBD) activity. We developed ex vivo autologous organoid-mucosal T cell cocultures to functionally assess lymphoepithelial interactions in Crohn’s Disease (CD) patients compared to controls. We demonstrate the direct epithelial cell death induced by autologous mucosal T cells in CD patients but not in controls. These findings were positively correlated with T cell infiltration of the organoids. This potential was inhibited by limiting lympho-epithelial interactions through CD103 and NKG2D blocking antibodies. These data directly demonstrate for the first time the direct deleterious effect of mucosal T cells on the epithelium of CD patients. Such ex-vivo models are promising techniques to unravel the pathophysiology of these diseases and the potential mode of action of current and future therapies.